Contact

Cellistic's Echo™: The platform for cell therapy manufacturing

Uniquely simplifying and accelerating the processes to take you from master cell bank to drug product.

Echo designer image
Allogeneic Cell Therapy-1

Smartly scaling your allogeneic cell therapy manufacturing.

Our Cellistic Echo™ Platform for cell therapy manufacturing picks up right where our Pulse™ Platform for renewable master cell line development leaves off. Through Cellistic Echo™, we provide your team with the pre-built differentiation and expansion platform that will help you to tackle the variability of your immunotherapy and scale it for clinical success. The end result is a powerful, reliable manufacturing process that helps enable accelerated timelines under cost-effective terms.

Deep, diverse cell type expertise.

iPSC-based cell therapy manufacturing is exceedingly complex. Fortunately, we’ve already taken on the critical process development work that’s essential to crafting scalable, cost-effective GMP manufacturing processes for your immunotherapy.

Our clients benefit from this experience and know-how obtained while optimizing this platform. And it translates into access to pre-established processes that can accelerate product development by multiple years – and do it under budget-smart terms.

Checkmark IconNK Cells
Checkmark Iconαβ T Cells
Checkmark Iconγδ T Cells
Checkmark IconMacrophages
Checkmark IconEndothelial Cells
Checkmark IconCardiomyocytes
_65A9407_R 4 (1)

Echo™-NK Platform: Scalable solutions for off-the-shelf NK cell therapy.

At Cellistic, we leverage our exclusive Cellistic Echo™ Platform to deliver manufacturing of NK therapies that hits all the right marks.

Accelerate Icon

Speed and cost-efficiency come through iPSC-based, off-the-shelf
solutions that leverage conventional technology and standardized
equipment to drive efficiency and scale.

Gear Icon-1

Safety comes through a process that minimizes off-target gene editing, eliminates the need for feeder cells, and lets patients avoid lympho-depletion.

Working_Icons 3

Confidence comes from robust GMP documentation and support for IND applications that ready you for regulatory review.

Turning every advantage toward you.

Cellistic's Echo™ Platform is designed with an acute focus on product quality, cost-effectiveness, and scalability. Equally important, the team behind Cellistic Echo knows how to bring standardization early into the process, expedite product development, and avoid common pitfalls.

Together, our people, processes, and platforms ideally position your team to benefit from:

Checkmark IconParallel differentiation and expansion ensuring yield more than 75 billion cells
Checkmark IconRemoved any cell process constrained isolation steps
Checkmark IconFacilities designed exclusively for iPSC-based allogeneic cell therapy manufacturing 
Checkmark IconWell-defined and scalable unit operations up to 50L clinical batches
Checkmark IconFeeder-free process
Checkmark IconOptimized medium composition
Checkmark IconClosed processing steps and fit-for-purpose vial filling operations
Group 35320-2

Tune our platforms and technologies to your exact needs.

The next steps are clear: You learn more about our platforms and technologies (and the experienced team behind them). We talk about your  immune oncology or regenerative medicine’s specific challenges and opportunities. And then together, we chart the ideal path to advance your program to commercial success.